| Name | cog 133 |
|---|
| Description | COG 133 is a fragment of Apolipoprotein E (APOE) peptide. COG 133 competes with the ApoE holoprotein for binding the LDL receptor, with potent anti-inflammatory and neuroprotective effects. COG 133 is also a nAChR antagonist with an IC50 of 445 nM[1][2]. |
|---|---|
| Related Catalog | |
| Target |
IC50: 445 nM (nAChR)[2] |
| References |
| Molecular Formula | C97H181N37O19 |
|---|---|
| Molecular Weight | 2169.71000 |
| Exact Mass | 2168.43000 |
| PSA | 948.24000 |
| LogP | 7.91900 |